Cardinal Health, Inc. (NYSE:CAH – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Thursday after Wells Fargo & Company raised their price target on the stock from $221.00 to $237.00. Wells Fargo & Company currently has an overweight rating on the stock. Cardinal Health traded as high as $214.93 and last traded at $214.43, with a volume of 103655 shares trading hands. The stock had previously closed at $213.56.
Several other brokerages have also weighed in on CAH. UBS Group upped their price objective on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $190.00 to $244.00 in a research note on Friday, January 9th. Deutsche Bank Aktiengesellschaft raised their price objective on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. TD Cowen upped their target price on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Finally, Mizuho set a $222.00 target price on Cardinal Health in a report on Monday. Fourteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $216.33.
Hedge Funds Weigh In On Cardinal Health
Cardinal Health Stock Performance
The business’s 50 day moving average is $205.19 and its two-hundred day moving average is $174.32. The firm has a market capitalization of $50.67 billion, a PE ratio of 32.16, a price-to-earnings-growth ratio of 1.52 and a beta of 0.65.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period last year, the company earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s payout ratio is presently 30.77%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Further Reading
- Five stocks we like better than Cardinal Health
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Look who’s buying 2 tonnes of gold… per week!
- Virtually Unknown AI Company Solving Trillion-Dollar Problem
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
